Amarin Corp Plc (AMRN)

[picasel]

Mercator; Excellent post, Very well stated and I also agree with you 98%. From my belief the FDA has very little to bargain with, now that's not to say they wouldn't try. I just think that with what has been documented in court transcripts, the Adcom, significant science, promises of further litigation among other things Amarin's attorneys are driving things thus the requests for more time from our attorneys. The extended time is slow governmental bureaucratic red tape. While I don't believe as yourself, that this has anything to do with early peeks for Reduce-it, they could be getting i's dotted and t's crossed so there is not another gotcha if an Adcom is needed for the Reduce-it indication. My understanding is Reduce-it is a third indication and market and thus failure, on the slim chance it would occur has nothing to do with the "very high Triglycerides market" which is the Anchor indication. I am opposed to anything that would jeopardize the sanctity of Reduce-it but if Amarin would allow that, I think they would do so only if it would make sense from a strategic point of view and only under advisement of their very capable attorneys and I would not be so quick to sell my shares although my finger would not be far from the trigger.

Good luck to us longs.